Evidence map›Paper›PMID 38005030›Full record

ArticleMaterials (Basel, Switzerland)2023

Modified Lignin-Based Cement Solidifying Material for Improving Engineering Residual Soil.

Xiang Yu, Hongbo Lu, Jie Peng, Jinming Ren, Yongmin Wang, Junhao Chen

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiang YuPower China Huadong Engineering Corporation Limited, Hangzhou 311122, China.
Hongbo LuPower China Huadong Engineering Corporation Limited, Hangzhou 311122, China.
Jie PengCollege of Civil and Transportation Engineering, Hohai University, Nanjing 210098, China.ORCID 0000-0003-4747-568X
Jinming RenPower China Huadong Engineering Corporation Limited, Hangzhou 311122, China.
Yongmin WangPower China Huadong Engineering Corporation Limited, Hangzhou 311122, China.
Junhao ChenPower China Huadong Engineering Corporation Limited, Hangzhou 311122, China.

Funding

China Postdoctoral Science Foundation 2022M712971National Key R&D Program of China 2022YFC3202704Zhejiang Natural Science Foundation Project LQ23E080009
6 · The paper itself

Abstract

Although lignin improves the strength and modulus of soil, it is less active when unmodified, and it exhibits more limited effects on soils in combination with traditional Ca-based curing agents. Lignin-solidified soil also exhibits deficiencies, such as poor durability under dry-wet cycling conditions, and thus, the amelioration effect is limited. This study investigated the enhancement of cement-solidified soil using hydroxylated lignin with sodium silicate and quicklime used as activators to improve the engineering performance and durability of the treated soil. Using respective cement, sodium silicate, quicklime, and lignin contents of 7%, 0.4%, 0.2%, and 0.2% with respect to the dry mass of the slag soil, the strength and cohesion of the composite-solidified soil were 1.5 times those of cement-solidified soil, whereas the internal friction angle increased by 5.1°. At a solidifying age of 14 d, the penetration resistance almost doubled, indicating a significant improvement in the bearing capacity of the soil. The results suggest that modified lignin-based admixtures may significantly enhance the performance of cement-solidified soil. The cement curing admixture used in this study provides theoretical and technological support for curing agent preparation and the utilization of slag.

Indexed as

hydroxylationligninsolidification mechanismsolidifying agent

Identifiers

PMID38005030
PMCPMC10672641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.